Sales of Illumina's MiSeq benchtop sequencer and sequencing consumables drove double-digit percent sequential revenue growth in the company's sequencing business for the first quarter of 2012, the company reported this week.

In the first quarter, Illumina "had record orders for both the MiSeq instrument and sequencing consumables," chief financial officer Marc Stapley said during a conference call to discuss the company's first quarter earnings.